A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer
A 45-year-old female developed neurological symptoms and elevated diastolic blood pressure while on bevacizumab (Avastin) and gemcitabine for recurrent carboplatin-resistant high-grade serous ovarian cancer. A brain MRI diagnosed our patient with posterior reversible encephalopathy syndrome. We are...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2015-07-01
|
| Series: | Case Reports in Oncology |
| Subjects: | |
| Online Access: | http://www.karger.com/Article/FullText/435805 |
| _version_ | 1818110441038020608 |
|---|---|
| author | Hind H. Elmalik Shereen ElAzzazy Khaled S. Salem Salha Bujassoum |
| author_facet | Hind H. Elmalik Shereen ElAzzazy Khaled S. Salem Salha Bujassoum |
| author_sort | Hind H. Elmalik |
| collection | DOAJ |
| description | A 45-year-old female developed neurological symptoms and elevated diastolic blood pressure while on bevacizumab (Avastin) and gemcitabine for recurrent carboplatin-resistant high-grade serous ovarian cancer. A brain MRI diagnosed our patient with posterior reversible encephalopathy syndrome. We are discussing her presenting symptoms in this paper as well as the management and the outcome. We emphasize the importance of keeping this rare but very serious complication in all patients receiving bevacizumab. |
| first_indexed | 2024-12-11T02:47:11Z |
| format | Article |
| id | doaj.art-36927306404f4e9f83a0499c8921575f |
| institution | Directory Open Access Journal |
| issn | 1662-6575 |
| language | English |
| last_indexed | 2024-12-11T02:47:11Z |
| publishDate | 2015-07-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Case Reports in Oncology |
| spelling | doaj.art-36927306404f4e9f83a0499c8921575f2022-12-22T01:23:24ZengKarger PublishersCase Reports in Oncology1662-65752015-07-018229029410.1159/000435805435805A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian CancerHind H. ElmalikShereen ElAzzazyKhaled S. SalemSalha BujassoumA 45-year-old female developed neurological symptoms and elevated diastolic blood pressure while on bevacizumab (Avastin) and gemcitabine for recurrent carboplatin-resistant high-grade serous ovarian cancer. A brain MRI diagnosed our patient with posterior reversible encephalopathy syndrome. We are discussing her presenting symptoms in this paper as well as the management and the outcome. We emphasize the importance of keeping this rare but very serious complication in all patients receiving bevacizumab.http://www.karger.com/Article/FullText/435805Posterior reversible encephalopathy syndromeBevacizumab |
| spellingShingle | Hind H. Elmalik Shereen ElAzzazy Khaled S. Salem Salha Bujassoum A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer Case Reports in Oncology Posterior reversible encephalopathy syndrome Bevacizumab |
| title | A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer |
| title_full | A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer |
| title_fullStr | A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer |
| title_full_unstemmed | A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer |
| title_short | A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer |
| title_sort | grave outcome of posterior reversible encephalopathy syndrome in a patient receiving avastin bevacizumab for metastatic high grade serous ovarian cancer |
| topic | Posterior reversible encephalopathy syndrome Bevacizumab |
| url | http://www.karger.com/Article/FullText/435805 |
| work_keys_str_mv | AT hindhelmalik agraveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT shereenelazzazy agraveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT khaledssalem agraveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT salhabujassoum agraveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT hindhelmalik graveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT shereenelazzazy graveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT khaledssalem graveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer AT salhabujassoum graveoutcomeofposteriorreversibleencephalopathysyndromeinapatientreceivingavastinbevacizumabformetastatichighgradeserousovariancancer |